Archives

Loading Events

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?

Please join us as we discuss recent clinical data on water intake practices, feasibility of conducting water trials, and results of a randomized controlled trial of prescribed water intake in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). In this presentation the impact of water intake on ADPKD disease progression including Total Kidney Volume (TKV) will be discussed.

Featuring

Andrea Noto

Andrea Noto, PharmD

Nephrology Clinical & Scientific Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Andrea Noto, PharmD, is a Nephrology Clinical & Scientific Liaison covering New York City & Long Island. She earned her PharmD at the University of Rhode Island in South Kingstown, RI. Prior to joining Otsuka in 2021, Dr Noto held various leadership roles in retail pharmacy for 15 years in the NJ and NYC regions. Most recently, she held the role of Doctor Partnership Manager for a retail pharmacy startup company and worked closely with Psychiatrists and Migraine Specialists. She is currently licensed in New Jersey and New York state.

Molly Jansen

Molly Jansen, PhD

Nephrology Clinical & Scientific Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Dr Molly Jansen is a Nephrology Clinical & Scientific Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. covering South Texas and New Mexico. Molly earned her Doctor of Philosophy degree in Biomedical Science from Wake Forest School of Medicine located in Winston-Salem, NC. While in graduate school, Molly worked as a Business Development Intern at Wake Forest Innovations, fostering the collaborative innovation between industry and the faculty and staff of Wake Forest Baptist Medical Center. After graduate school, Molly did a brief Medical Writing Fellowship with Impact Pharmaceutical Services. Prior to joining Otsuka, Molly worked at Reata Pharmaceuticals, Inc. where she helped to oversee the conduct of clinical trials across a variety of therapeutic areas including nephrology, neurology, and pulmonary, which is where she developed her passion for rare disease.

*Drs Noto and Jansen are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).

Registration

Please Log In Or Join to Register for this Event.

Related Resources